Int J Thyroidol.  2022 May;15(1):54-59. 10.11106/ijt.2022.15.1.54.

Thyroid Dyshormonogenesis Due to Dual Oxidase Maturation Factor 2 Mutation as Non-Transient Status of Hypothyroidism

• Lee J
• Kim Sg
• Oh A
• Han HS

• KMID: 2530127
• DOI: http://doi.org/10.11106/ijt.2022.15.1.54

Abstract

Dual oxidase maturation factor 2 (DUOXA2) is necessary for the enzymatic activity of dual oxidase 2 (DUOX2) to generate hydrogen peroxide production during thyroid hormone synthesis. We describe two Korean children, who were initially suspected to have transient congenital hypothyroidism (CH), but later confirmed to have permanent CH caused by DUOXA2 mutation. Treatment with levothyroxine was discontinued after confirming thyroid-stimulating hormone (TSH) level to be below 10 μU/mL and normal thyroid scan at the first or second trial-off therapy. However, after therapy cessation, TSH elevated to more than 10 μU/mL, and goiter developed in case 2. As a result, levothyroxine was resumed. Next-generation sequencing showed compound heterozygous mutations of DUOXA2 at Y138X and Y246X in case 1 and homozygous mutations of DUOXA2 at Y246X in case 2. In this report, a longer follow-up is recommended even after treatment termination in transient CH, and genetic studies might help assess the permanence of hypothyroidism in cases of mildly elevated TSH after trial-off therapy.

Keyword

Congenital hypothyroidism; Thyroid dyshormonogenesis; DUOXA2

Reference

References

1. Rastogi MV, LaFranchi SH. 2010; Congenital hypothyroidism. Orphanet J Rare Dis. 5:17. DOI: 10.1186/1750-1172-5-17. PMID: 20537182. PMCID: PMC2903524.

2. Peters C, van Trotsenburg ASP, Schoenmakers N. 2018; Diagnosis of endocrine disease: congenital hypothyroidism: update and perspectives. Eur J Endocrinol. 179(6):R297–R317. DOI: 10.1530/EJE-18-0383. PMID: 30324792.

3. Grasberger H, Refetoff S. 2011; Genetic causes of congenital hypothyroidism due to dyshormonogenesis. Curr Opin Pediatr. 23(4):421–8. DOI: 10.1097/MOP.0b013e32834726a4. PMID: 21543982. PMCID: PMC3263319.

4. Grosse SD, Van Vliet G. 2011; Prevention of intellectual disability through screening for congenital hypothyroidism: how much and at what level? Arch Dis Child. 96(4):374–9. DOI: 10.1136/adc.2010.190280. PMID: 21242230.

5. Rose SR, Brown RS, et al. American Academy of Pediatrics. Section on Endocrinology and Committee on Genetics. American Thyroid Association. Public Health Committee. Lawson Wilkins Pediatric Endocrine Society. 2006; Update of newborn screening and therapy for congenital hypothyroidism. Pediatrics. 117(6):2290–303. DOI: 10.1542/peds.2006-0915. PMID: 16740880.

6. Revised guidelines for neonatal screening programmes for primary congenital hypothyroidism. 1999; Working Group on Neonatal Screening of the European Society for Paediatric Endocrinology. Horm Res. 52(1):49–52. DOI: 10.1159/000023433. PMID: 10640901.

7. Szanto Iidiko, Pusztaszeri M, Mavromati M. 2019; H2O2 metabolism in normal thyroid cells and in thyroid tumorigenesis: focus on NADPH oxidases. Antioxidants (Basel). 8:126. DOI: 10.3390/antiox8050126. PMID: 31083324. PMCID: PMC6563055.

8. Grasberger H, Refetoff S. 2006; Identification of the maturation factor for dual oxidase. Evolution of an eukaryotic operon equivalent. J Biol Chem. 281(27):18269–72. DOI: 10.1074/jbc.C600095200. PMID: 16651268.

9. Kalantari S, Moghadam MV. 2015; Thyroid gland volume of schoolchildren in the North of Iran: comparison with other studies. J Res Med Sci. 20(11):1070–6. DOI: 10.4103/1735-1995.172824. PMID: 26941811. PMCID: PMC4755094.

10. Leger J, Olivieri A, Donaldson M, Torresani T, Krude H, van Vliet G, et al. 2014; European Society for Paediatric Endocrinology consensus guidelines on screening, diagnosis, and management of congenital hypothyroidism. Horm Res Paediatr. 81(2):80–103. DOI: 10.1159/000358198. PMID: 24662106.

11. Kanike N, Davis A, Shekhawat PS. 2017; Transient hypothyroidism in the newborn: to treat or not to treat. Transl Pediatr. 6(4):349–58. DOI: 10.21037/tp.2017.09.07. PMID: 29184815. PMCID: PMC5682382.

12. Cho MS, Cho GS, Park SH, Jung MH, Suh BK, Koh DG. 2014; Earlier re-evaluation may be possible in pediatric patients with eutopic congenital hypothyroidism requiring lower L-thyroxine doses. Ann Pediatr Endocrinol Metab. 19(3):141–5. DOI: 10.6065/apem.2014.19.3.141. PMID: 25346918. PMCID: PMC4208263.

13. Fisher DA. Sperling MA, editor. 2002. Disorders of the thyroid in the newborn and infant. Clinical pediatric and adolescent endocrinology. 3rd ed. Saunders;Philadelphia, PA: p. 164. DOI: 10.1016/b978-141604090-3.50011-9.

14. Targovnik HM, Citterio CE, Rivolta CM. 2017; Iodide handling disorders (NIS, TPO, TG, IYD). Best Pract Res Clin Endocrinol Metab. 31(2):195–212. DOI: 10.1016/j.beem.2017.03.006. PMID: 28648508.

15. Morand S, Ueyama T, Tsujibe S, Saito N, Korzeniowska A, Leto TL. 2009; Duox maturation factors form cell surface complexes with Duox affecting the specificity of reactive oxygen species generation. FASEB J. 23(4):1205–18. DOI: 10.1096/fj.08-120006. PMID: 19074510. PMCID: PMC2660643.

16. Park KJ, Park HK, Kim YJ, Lee KR, Park JH, Park JH, et al. 2016; DUOX2 Mutations are frequently associated with congenital hypothyroidism in the Korean population. Ann Lab Med. 36(2):145–53. DOI: 10.3343/alm.2016.36.2.145. PMID: 26709262. PMCID: PMC4713848.

17. Zamproni I, Grasberger H, Cortinovis F, Vigone MC, Chiumello G, Mora S, et al. 2008; Biallelic inactivation of the dual oxidase maturation factor 2 (DUOXA2) gene as a novel cause of congenital hypothyroidism. J Clin Endocrinol Metab. 93(2):605–10. DOI: 10.1210/jc.2007-2020. PMID: 18042646. PMCID: PMC2243227.

18. Yi RH, Zhu WB, Yang LY, Lan L, Chen Y, Zhou JF, et al. 2013; A novel dual oxidase maturation factor 2 gene mutation for congenital hypothyroidism. Int J Mol Med. 31(2):467–70. DOI: 10.3892/ijmm.2012.1223. PMID: 23292166.

19. Liu S, Liu L, Niu X, Lu D, Xia H, Yan S. 2015; A novel missense mutation (I26M) in DUOXA2 causing congenital goiter hypothyroidism impairs NADPH oxidase activity but not protein expression. J Clin Endocrinol Metab. 100(4):1225–9. DOI: 10.1210/jc.2014-3964. PMID: 25675383.

20. Jung SY, Lee J, Lee DH. 2020; Persistent goiter with congenital hypothyroidism due to mutation in DUOXA2 gene. Ann Pediatr Endocrinol Metab. 25(1):57–62. DOI: 10.6065/apem.2020.25.1.57. PMID: 32252219. PMCID: PMC7136507.